AKT1 and breast cancer: Moreover, PI3K inhibitor PI3K‐IN‐6 treatment combined with Kushenol A further attenuated phosphorylation of AKT and mTOR in BC cells, with no notable effect on PI3K expression (Figure 5C,D).